Visible light therapy: molecular mechanisms and therapeutic opportunities

Z.C. Felix Garza, M. Born, P.A.J. Hilbers, N.A.W. van Riel, J. Liebmann

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
1 Downloads (Pure)

Abstract

Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near infrared regions of the visible spectrum. However, considerably less effort has been dedicated to the UV-free blue part of the spectrum. In this review we discuss the current advances in the understanding of the molecular photoacceptors, downstream signaling mechanisms and the corresponding therapeutic opportunities in the context of inflammatory skin conditions of blue light photoreception in mammalian cells. At a molecular level, blue light is absorbed by flavins, porphyrins, nitrosated proteins and opsins, and induces the release of reactive oxygen species, nitric oxide, and activation of G protein coupled signaling, respectively. Limited and contrasting results have been reported on the downstream cellular effects of blue light induced signaling. Some investigations describe a regulation of cellular proliferation and differentiation or a modulation of inflammatory parameters while others show growth inhibition and apoptosis. Regardless of the elusive underlying mechanism, blue light has been shown to be beneficial in treating inflammatory skin conditions, which are characterized by sustained inflammation and hyperproliferation of skin cells. However, to strengthen the use of UV-free blue light for therapeutic applications, further in depth studies of the underlying molecular and cellular mechanisms and their translation into clinical applications are clearly needed.

Original languageEnglish
Pages (from-to)5564-5577
JournalCurrent Medicinal Chemistry
Volume25
Issue number40
Early online date27 Jul 2017
DOIs
Publication statusPublished - 2018

Fingerprint

Phototherapy
Light
Skin
Therapeutics
Cells
Flavins
Modulation
Opsins
Porphyrins
GTP-Binding Proteins
Reactive Oxygen Species
Nitric Oxide
Chemical activation
Cell Proliferation
Apoptosis
Inflammation
Infrared radiation
Growth
Proteins

Keywords

  • Journal Article

Cite this

Felix Garza, Z.C. ; Born, M. ; Hilbers, P.A.J. ; van Riel, N.A.W. ; Liebmann, J. / Visible light therapy : molecular mechanisms and therapeutic opportunities. In: Current Medicinal Chemistry. 2018 ; Vol. 25, No. 40. pp. 5564-5577.
@article{22297be4fed8445c90ddcbddb1b32cbc,
title = "Visible light therapy: molecular mechanisms and therapeutic opportunities",
abstract = "Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near infrared regions of the visible spectrum. However, considerably less effort has been dedicated to the UV-free blue part of the spectrum. In this review we discuss the current advances in the understanding of the molecular photoacceptors, downstream signaling mechanisms and the corresponding therapeutic opportunities in the context of inflammatory skin conditions of blue light photoreception in mammalian cells. At a molecular level, blue light is absorbed by flavins, porphyrins, nitrosated proteins and opsins, and induces the release of reactive oxygen species, nitric oxide, and activation of G protein coupled signaling, respectively. Limited and contrasting results have been reported on the downstream cellular effects of blue light induced signaling. Some investigations describe a regulation of cellular proliferation and differentiation or a modulation of inflammatory parameters while others show growth inhibition and apoptosis. Regardless of the elusive underlying mechanism, blue light has been shown to be beneficial in treating inflammatory skin conditions, which are characterized by sustained inflammation and hyperproliferation of skin cells. However, to strengthen the use of UV-free blue light for therapeutic applications, further in depth studies of the underlying molecular and cellular mechanisms and their translation into clinical applications are clearly needed.",
keywords = "Journal Article",
author = "{Felix Garza}, Z.C. and M. Born and P.A.J. Hilbers and {van Riel}, N.A.W. and J. Liebmann",
note = "Copyright{\circledC} Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.",
year = "2018",
doi = "10.2174/0929867324666170727112206",
language = "English",
volume = "25",
pages = "5564--5577",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "40",

}

Visible light therapy : molecular mechanisms and therapeutic opportunities. / Felix Garza, Z.C.; Born, M.; Hilbers, P.A.J.; van Riel, N.A.W.; Liebmann, J.

In: Current Medicinal Chemistry, Vol. 25, No. 40, 2018, p. 5564-5577.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Visible light therapy

T2 - molecular mechanisms and therapeutic opportunities

AU - Felix Garza, Z.C.

AU - Born, M.

AU - Hilbers, P.A.J.

AU - van Riel, N.A.W.

AU - Liebmann, J.

N1 - Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

PY - 2018

Y1 - 2018

N2 - Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near infrared regions of the visible spectrum. However, considerably less effort has been dedicated to the UV-free blue part of the spectrum. In this review we discuss the current advances in the understanding of the molecular photoacceptors, downstream signaling mechanisms and the corresponding therapeutic opportunities in the context of inflammatory skin conditions of blue light photoreception in mammalian cells. At a molecular level, blue light is absorbed by flavins, porphyrins, nitrosated proteins and opsins, and induces the release of reactive oxygen species, nitric oxide, and activation of G protein coupled signaling, respectively. Limited and contrasting results have been reported on the downstream cellular effects of blue light induced signaling. Some investigations describe a regulation of cellular proliferation and differentiation or a modulation of inflammatory parameters while others show growth inhibition and apoptosis. Regardless of the elusive underlying mechanism, blue light has been shown to be beneficial in treating inflammatory skin conditions, which are characterized by sustained inflammation and hyperproliferation of skin cells. However, to strengthen the use of UV-free blue light for therapeutic applications, further in depth studies of the underlying molecular and cellular mechanisms and their translation into clinical applications are clearly needed.

AB - Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near infrared regions of the visible spectrum. However, considerably less effort has been dedicated to the UV-free blue part of the spectrum. In this review we discuss the current advances in the understanding of the molecular photoacceptors, downstream signaling mechanisms and the corresponding therapeutic opportunities in the context of inflammatory skin conditions of blue light photoreception in mammalian cells. At a molecular level, blue light is absorbed by flavins, porphyrins, nitrosated proteins and opsins, and induces the release of reactive oxygen species, nitric oxide, and activation of G protein coupled signaling, respectively. Limited and contrasting results have been reported on the downstream cellular effects of blue light induced signaling. Some investigations describe a regulation of cellular proliferation and differentiation or a modulation of inflammatory parameters while others show growth inhibition and apoptosis. Regardless of the elusive underlying mechanism, blue light has been shown to be beneficial in treating inflammatory skin conditions, which are characterized by sustained inflammation and hyperproliferation of skin cells. However, to strengthen the use of UV-free blue light for therapeutic applications, further in depth studies of the underlying molecular and cellular mechanisms and their translation into clinical applications are clearly needed.

KW - Journal Article

U2 - 10.2174/0929867324666170727112206

DO - 10.2174/0929867324666170727112206

M3 - Article

C2 - 28748760

VL - 25

SP - 5564

EP - 5577

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 40

ER -